Lysosomal Dysfunction Promotes Cleavage and Neurotoxicity of Tau In Vivo

DSpace/Manakin Repository

Lysosomal Dysfunction Promotes Cleavage and Neurotoxicity of Tau In Vivo

Citable link to this page

. . . . . .

Title: Lysosomal Dysfunction Promotes Cleavage and Neurotoxicity of Tau In Vivo
Author: Elson-Schwab, Ilan; Sharp, Katherine A.; Loewen, Carin A.; Mulkearns, Erin; Tyynelä, Jaana; Khurana, Vikram; Fulga, Tudor Alexandru; Scherzer, Clemens; Feany, Mel B.

Note: Order does not necessarily reflect citation order of authors.

Citation: Khurana, Vikram, Ilan Elson-Schwab, Tudor A. Fulga, Katherine A. Sharp, Carin A. Loewen, Erin Mulkearns, Jaana Tyynelä, Clemens R. Scherzer, and Mel B. Feany. 2010. Lysosomal Dysfunction Promotes Cleavage and Neurotoxicity of Tau . PLoS Genetics 6, no. 7: e1001026.
Full Text & Related Files:
Abstract: Expansion of the lysosomal system, including cathepsin D upregulation, is an early and prominent finding in Alzheimer's disease brain. Cell culture studies, however, have provided differing perspectives on the lysosomal connection to Alzheimer's disease, including both protective and detrimental influences. We sought to clarify and molecularly define the connection in vivo in a genetically tractable model organism. Cathepsin D is upregulated with age in a Drosophila model of Alzheimer's disease and related tauopathies. Genetic analysis reveals that cathepsin D plays a neuroprotective role because genetic ablation of cathepsin D markedly potentiates tau-induced neurotoxicity. Further, generation of a C-terminally truncated form of tau found in Alzheimer's disease patients is significantly increased in the absence of cathepsin D. We show that truncated tau has markedly increased neurotoxicity, while solubility of truncated tau is decreased. Importantly, the toxicity of truncated tau is not affected by removal of cathepsin D, providing genetic evidence that modulation of neurotoxicity by cathepsin D is mediated through C-terminal cleavage of tau. We demonstrate that removing cathepsin D in adult postmitotic neurons leads to aberrant lysosomal expansion and caspase activation in vivo, suggesting a mechanism for C-terminal truncation of tau. We also demonstrate that both cathepsin D knockout mice and cathepsin D–deficient sheep show abnormal C-terminal truncation of tau and accompanying caspase activation. Thus, caspase cleavage of tau may be a molecular mechanism through which lysosomal dysfunction and neurodegeneration are causally linked in Alzheimer's disease.
Published Version: doi://10.1371/journal.pgen.1001026
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904797/pdf/
www.plosgenetics.org
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8160859

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters